Prescription patterns in patients with schizophrenia discontinuing long-acting injectable antipsychotics: A chart-review

被引：0
|
作者：
Asano, K. [1 ]
Uchida, H. [2 ]
Ueno, F. [2 ]
Mizuno, Y. [2 ]
Yoshida, K. [2 ]
Mimura, M. [2 ]
Suzuki, T. [3 ]
机构：
[1] Inokashira Hosp, Dept Psychiat, Tokyo, Japan
[2] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan
[3] Univ Yamanashi, Dept Neuropsychiat & Clin Eth, Fac Med, Yamanashi, Japan
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2019年 / 29卷
关键词：
D O I：
10.1016/j.euroneuro.2019.09.151
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.097
引用
收藏
页码：S83 / S84
页数：2
相关论文
共 50 条
  • [21] Long-acting injectable versus oral antipsychotics for schizophrenia reply
    Kishimoto, Taishiro
    Hagi, Katsuhiko
    Kurokawa, Shunya
    Kane, John M.
    Correll, Christoph U.
    LANCET PSYCHIATRY, 2021, 8 (07): : 567 - 567
  • [22] Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia
    Parellada, Eduard
    Velligan, Dawn I.
    Emsley, Robin
    Kissling, Werner
    SCHIZOPHRENIA RESEARCH AND TREATMENT, 2012, 2012
  • [23] What Is the Role of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia?
    Stroup, T. Scott
    JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (11) : 1261 - 1262
  • [24] Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
    Sugawara, Norio
    Kudo, Shuhei
    Ishioka, Masamichi
    Sato, Yasushi
    Kubo, Kazutoshi
    Yasui-Furukori, Norio
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 205 - 211
  • [25] The impact of efficacy of long-acting injectable antipsychotics on caregivers' burden of patients with schizophrenia
    Capuzzi, Enrico
    Quitadamo, Cecilia
    Caldiroli, Alice
    Clerici, Massimo
    Buoli, Massimiliano
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2024, 39 (05) : 333 - 335
  • [26] IMPACT OF INITIATION OF LONG-ACTING INJECTABLE ANTIPSYCHOTICS ON RESOURCE UTILIZATION IN PATIENTS WITH SCHIZOPHRENIA
    Lachaine, J.
    Larbi, M.
    Melnyk, P.
    Rouleau, A.
    Baribeau, V
    Stip, E.
    VALUE IN HEALTH, 2016, 19 (07) : A605 - A605
  • [27] The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the Evidence
    Correll, Christoph U.
    Citrome, Leslie
    Haddad, Peter M.
    Lauriello, John
    Olfson, Mark
    Calloway, Stephen M.
    Kane, John M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2016, 77 : 3 - +
  • [28] Impact of long-acting injectable antipsychotics on the illness progression in schizophrenia
    Saiz, P. A.
    EUROPEAN PSYCHIATRY, 2015, 30 (08) : S50 - S50
  • [29] Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia
    Parellada, Eduard
    Bioque, Miquel
    CNS DRUGS, 2016, 30 (08) : 689 - 701
  • [30] Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia
    Eduard Parellada
    Miquel Bioque
    CNS Drugs, 2016, 30 : 689 - 701
12345